[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TNSN98175A1 - Implant contenant un parasiticide, et procede pour sa production - Google Patents

Implant contenant un parasiticide, et procede pour sa production

Info

Publication number
TNSN98175A1
TNSN98175A1 TNTNSN98175A TNSN98175A TNSN98175A1 TN SN98175 A1 TNSN98175 A1 TN SN98175A1 TN TNSN98175 A TNTNSN98175 A TN TNSN98175A TN SN98175 A TNSN98175 A TN SN98175A TN SN98175 A1 TNSN98175 A1 TN SN98175A1
Authority
TN
Tunisia
Prior art keywords
production
implant
parasiticide
implant containing
compound
Prior art date
Application number
TNTNSN98175A
Other languages
English (en)
French (fr)
Inventor
Huatan Hiep
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN98175A1 publication Critical patent/TNSN98175A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TNTNSN98175A 1997-09-23 1998-09-22 Implant contenant un parasiticide, et procede pour sa production TNSN98175A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
TNSN98175A1 true TNSN98175A1 (fr) 2005-03-15

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98175A TNSN98175A1 (fr) 1997-09-23 1998-09-22 Implant contenant un parasiticide, et procede pour sa production

Country Status (13)

Country Link
EP (1) EP1014970A1 (es)
JP (1) JP2001517622A (es)
AP (1) AP9801350A0 (es)
AR (1) AR013509A1 (es)
AU (1) AU9742298A (es)
BR (1) BR9812385A (es)
CA (1) CA2304283A1 (es)
GT (1) GT199800149A (es)
MA (1) MA24655A1 (es)
PA (1) PA8459501A1 (es)
PE (1) PE117199A1 (es)
TN (1) TNSN98175A1 (es)
WO (1) WO1999015166A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
WO2001037811A1 (en) * 1999-11-22 2001-05-31 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
US20200179273A1 (en) * 2017-06-06 2020-06-11 Merck Sharp & DohmeCorp Long-action implant for treatment of infectious diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
GT199800149A (es) 2000-03-15
AP9801350A0 (en) 2000-03-17
WO1999015166A1 (en) 1999-04-01
AR013509A1 (es) 2000-12-27
AU9742298A (en) 1999-04-12
PA8459501A1 (es) 2000-05-24
JP2001517622A (ja) 2001-10-09
BR9812385A (pt) 2000-09-12
CA2304283A1 (en) 1999-04-01
MA24655A1 (fr) 1999-04-01
PE117199A1 (es) 1999-11-20
EP1014970A1 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
TNSN98175A1 (fr) Implant contenant un parasiticide, et procede pour sa production
HU9600299D0 (en) Substituted azadioxacycloalkenes, fungicidal compositions containing them, process for the preparation of the compounds and the fungicidal compositions and method for combating fungi
ES2099501T3 (es) Combinaciones de productos activos fungicidas.
PL348355A1 (en) Fungicidal active substance combinations
AU5106996A (en) Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby
DZ2639A1 (fr) Composés thérapeutiquement actifs basés sur le remplacement bio-isostérique du catéchol par l'indazole dans des inhibiteurs de PDE4 leur procédé de production et compositions pharmaceutiques les contenant.
AU6738696A (en) Halobenzimidazoles and their use as microbicides
BR9909332A (pt) Método & produto de tratamento de água
YU23102A (sh) Jedinjenja za lečenje ishemije
FR2780403B3 (fr) Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
AU3366297A (en) Polymorphic compounds
AU699480B2 (en) 2,2-Dichloroalkane carboxylic acids, processes for their production and pharmaceutical agents containing these
AU6200599A (en) Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of acomposition for the treatment of ischemic stroke
CA2364819A1 (en) Process for the preparation of iopamidol
TNSN00106A1 (fr) Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procede pour sa preparation
MXPA02011039A (es) Combinaciones de productos activos fungicidas.
ATE234008T1 (de) Synergistische fungizide zusammensetzung, die eine strobilurin - ähnliche verbindung enthalt
EP1420066A3 (en) Use of fullerene derivatives as DNA compaction agent
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
CA2321683A1 (en) Additives to chlorine dioxide bleaching
TW360493B (en) Fungicidal mixtures and a method of controlling fungi using the same
TW200501970A (en) Use of PVP-iodine liposomes for treatment of acne
MA27662A1 (fr) Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
AU3031297A (en) N-sulfonylimidazoles used as fungicides
MXPA04006040A (es) Composicion con filtro solar que comprende clorfenesina.